GlassScriptPhysician profile
Arun Rajan
NPI 1609825181
$1,079.92
in general payments reported to CMS, 2019-2025
25 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $35.31 · 2021: $178 · 2022: $16.67 · 2023: $199 · 2024: $300 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $156.61 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $144.01 | 2023-2025 | Austedo Xr, Austedo Xr |
| Lilly USA, LLC | $106.04 | 2023-2025 | Emgality, Amyvid, Kisunla |
| Novartis Pharmaceuticals Corporation | $71.74 | 2019-2021 | |
| Ucb, INC. | $68.23 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $63.09 | 2023-2024 | Rexulti |
| Axsome Therapeutics, INC. | $47.65 | 2023-2024 | Sunosi |
| Supernus Pharmaceuticals, INC. | $47.24 | 2019-2020 | |
| Eisai INC. | $38.00 | 2023 | |
| Pfizer INC. | $36.99 | 2021-2023 | |
| Noctrix Health, INC. | $30.68 | 2025 | Nidra |
| Janssen Pharmaceuticals, INC | $30.56 | 2021 | |
| Inspire Medical Systems, INC. | $24.42 | 2025 | Inspire |
| Sk Life Science, INC. | $23.93 | 2025 | |
| Neurelis, INC. | $22.85 | 2025 | Valtoco |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $22.25 | 2019 | |
| Lundbeck LLC | $21.52 | 2024 | Rexulti |
| Amylyx Pharmaceuticals, INC. | $19.66 | 2024 | Relyvrio |
| Jazz Pharmaceuticals INC. | $17.11 | 2021 | |
| 3b Medical, INC. | $16.69 | 2025 | Luna |
| Life Molecular Imaging LTD | $16.05 | 2024 | Neuraceq |
| Harmony Biosciences LLC | $15.52 | 2024 | |
| Astellas Pharma US INC | $14.81 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.65 | 2021 | |
| Allergan, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.